Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;25(3):181-185.
doi: 10.1007/s12471-016-0939-y.

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group

P Damman  1 , A W van 't Hof  2 , J M Ten Berg  3 , J W Jukema  4 , Y Appelman  5 , A H Liem  6 , R J de Winter  7
Affiliations

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group

P Damman et al. Neth Heart J. 2017 Mar.

Abstract

On behalf of the Dutch ACS working group, we discuss multiple recommendations which have been implemented in the 2015 ESC guidelines for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation.

Keywords: NSTE-ACS guidelines; NVVC ACS working group statement.

PubMed Disclaimer

Conflict of interest statement

P. Damman, A.W. van ’t Hof, J.M. ten Berg, J.W. Jukema, Y. Appelman, A.H. Liem and R.J. de Winter declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
0 h/3 h rule-out algorithms using high-sensitivity cardiac troponin assays in patients presenting to the emergency department with suspected non-ST-elevation myocardial infarction (With permission of Oxford University Press (UK)© European Society of Cardiology, www.escardio.org)
Fig. 2
Fig. 2
0 h/1 h rule-in and rule-out algorithms using high-sensitivity cardiac troponin assays in patients presenting to the emergency department with suspected non-ST-elevation myocardial infarction (With permission of Oxford University Press (UK)© European Society of Cardiology, www.escardio.org)
Fig. 3
Fig. 3
Antithrombotic strategies in patients with non-ST-elevation acute coronary syndromes and non-valvular atrial fibrillation (With permission of Oxford University Press (UK)© European Society of Cardiology, www.escardio.org)
Fig. 4
Fig. 4
Selection of non-ST-elevation acute coronary syndrome treatment strategy and timing according to initial risk stratification (With permission of Oxford University Press (UK)© European Society of Cardiology, www.escardio.org)
See this image and copyright information in PMC

References

    1. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) Eur Heart J. 2016;37:267–315. doi: 10.1093/eurheartj/ehv320. - DOI - PubMed
    1. Mueller C. Biomarkers and acute coronary syndromes: an update. Eur Heart J. 2014;35:552–556. doi: 10.1093/eurheartj/eht530. - DOI - PubMed
    1. Hamm CW, Bassand JP, Agewall S, et al. ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2011;32:2999–3054. doi: 10.1093/eurheartj/ehr236. - DOI - PubMed
    1. ACCOAST Investigators. Montalescot G, Bolognese L, Dudek D, et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med. 2013;369:999–1010. doi: 10.1056/NEJMoa1308075. - DOI - PubMed
    1. Hansen ML, Sørensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170:1433–1441. doi: 10.1001/archinternmed.2010.271. - DOI - PubMed

LinkOut - more resources